Cargando…
Therapeutic and Vaccine Options for COVID-19: Status after Six Months of the Disease Outbreak
An outbreak of the coronavirus disease 2019 (COVID-19) caused by an infection of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, in December 2019. This new virus belongs to the group of enveloped RNA beta-coronaviruses. Symptoms may differ in various...
Autores principales: | Maciorowski, Dawid, Ogaugwu, Christian, Durvasula, Subba Rao, Durvasula, Ravi, Kunamneni, Adinarayana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Laboratory Automation and Screening. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940856/ https://www.ncbi.nlm.nih.gov/pubmed/33319627 http://dx.doi.org/10.1177/2472555220979579 |
Ejemplares similares
-
Ribosome Display Technology: Applications in Disease Diagnosis and Control
por: Kunamneni, Adinarayana, et al.
Publicado: (2020) -
Ribosome display for the rapid generation of high-affinity Zika-neutralizing single-chain antibodies
por: Kunamneni, Adinarayana, et al.
Publicado: (2018) -
Environmental factors and their role in the transmission of SARS-CoV-2
por: Maciorowski, Dawid, et al.
Publicado: (2021) -
Generation and Selection of a Panel of Pan-Filovirus Single-Chain Antibodies using Cell-Free Ribosome Display
por: Kunamneni, Adinarayana, et al.
Publicado: (2019) -
Rapid Generation and Molecular Docking Analysis of Single-Chain Fragment Variable (scFv) Antibody Selected by Ribosome Display Targeting Cholecystokinin B Receptor (CCK-BR) for Reduction of Chronic Neuropathic Pain
por: Kunamneni, Adinarayana, et al.
Publicado: (2023)